| Literature DB >> 35643079 |
Leah Guthrie1, Sean Paul Spencer2, Dalia Perelman3, Will Van Treuren1, Shuo Han1, Feiqiao Brian Yu4, Erica D Sonnenburg1, Michael A Fischbach5, Timothy W Meyer6, Justin L Sonnenburg7.
Abstract
Gut microbiota metabolism of dietary compounds generates a vast array of microbiome-dependent metabolites (MDMs), which are highly variable between individuals. The uremic MDMs (uMDMs) phenylacetylglutamine (PAG), p-cresol sulfate (PCS), and indoxyl sulfate (IS) accumulate during renal failure and are associated with poor outcomes. Targeted dietary interventions may reduce toxic MDM generation; however, it is unclear if inter-individual differences in diet or gut microbiome dominantly contribute to MDM variance. Here, we use a 7-day homogeneous average American diet to standardize dietary precursor availability in 21 healthy individuals. During dietary homogeneity, the coefficient of variation in PAG, PCS, and IS (primary outcome) did not decrease, nor did inter-individual variation in most identified metabolites; other microbiome metrics showed no or modest responses to the intervention. Host identity and age are dominant contributors to variability in MDMs. These results highlight the potential need to pair dietary modification with microbial therapies to control MDM profiles.Entities:
Keywords: dietary intervention; microbiome; microbiome-dependent metabolites; precision medicine; uremic solutes
Mesh:
Substances:
Year: 2022 PMID: 35643079 PMCID: PMC9296065 DOI: 10.1016/j.chom.2022.05.003
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 31.316